Spondyloarthritis in Senegal: a study of 770 cases
##plugins.themes.academic_pro.article.main##
Abstract
Abstract
Background : Very few studies have focused on spondyloarthritis (SpA) in sub-Saharan Africa. The majority of these studies have focused on series of HLA B27-negative SpA. Objective: To determine the epidemiological, diagnostic, therapeutic and evolutionary aspects of SpA in the rheumatology department of the CHU Aristide LeDantec in Dakar, Senegal.
Methods : We conducted a retrospective, descriptive, analytical study from January 1, 2012 to December 31, 2020, of patients with spondyloarthritis diagnosed according to the ESSG (54.5%), Amor (52.5%), modified New York criteria (48.3%) and ASAS (23%). For each patient, the following information was collected: sex, age, occupation, family history of spondyloarthritis in the parents, time to diagnosis, type of SpA.
Results : 770 observations were collected from 273 men (35.5%) and 497 women (64.5%). Ankylosing spondylitis (AS) was the most frequent type of SpA in our series with 84% of cases. A biological inflammatory syndrome was present in 77.27% of our patients. HLA B27 phenotyping was performed in 437 patients, of which 225 were HLA B27 positive (51.48%). The majority of our patients were under conventional treatment due to the high cost of biotherapies which limits their prescription.
Conclusion: The profile of SpA patients in our series was characterised by : the predominance of females, the later age of onset, the frequency of radiographic axial forms of SpA and the biological inflammatory syndrome. HLA B27 was present in one patient out of two, as in the North African series.
Keywords:
Spondyloarthritis, HLA B 27, Senegal##plugins.themes.academic_pro.article.details##
References
- 1. Saraux A, Guillemin F, Guggenbuhl P. Prevalence of spondyloarthropathies in France : 2001. Ann Rheum Dis 2005 ; 64: 1431-5. 2. Saraux A, Guedes C, Allain J. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest. J Rheumatol. 1999; 26(12):2622-7. 3. Cotten A, Philippe P, Flipo R.M. Imagerie musculosquelettique. Pathologie générale. 2èédition. 4. Sibilia J, Pham T, Sordet C, Jaulhac B, Claudepierre P. Spondylarthrite ankylosante et autres spondylarthropathies. EMC-Médecine 2005 ; 2 : 488 -511. 5. Adomaviciute D, Pileckyte M, Baranauskaite A. Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand J Rheumatol. 2008; 37(2):113-9. 6. Slimani, S., Hamdi, W., Nassar, K. et al. Spondyloarthritis in North Africa: an update. Clin Rheumatol (2021). https://doi.org/10.1007/s10067-021-05630-w 7. Condé Kaba C, Niasse M, Salissou GM. European Scientific Journal March 2019 edition Vol.15, No.9 ISSN:1857-7881 (Print)e-ISSN1857-7431 8. Ra A-C. Épidémiologie de la spondyloarthrite au xxie siècle. Revue du rhumatisme monographies 2014;81:225-229. 9. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of assessment of spondyloarthritis international society (ASAS) classification criteria for axial spondyloarthritis. Ann Rheum Dis 2009;68:777-83. 10. Hassouni N, Maetzel A, Dougados M., Amor B. Comparaison des malades examinés pour spondylarthropathies en France et au Maroc. Rev Rhum 1993;60:420- 5. 11. Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005;53:850-5. 12. Trontzas P, Andrianakos A, Miyakis S, et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 2005;24:583-9 13. De Angelis R. Salaffi F. Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community based study. Scand J Rheumatol 2007;36(1):14-21. 14. Casals-Sánchez L. et al. Characteristics of Patients With Spondyloarthritis Followed in Rheumatology Units in Spain. Em AR II Study. Rheumatol Clin 2012;8(3):107-13 15. Sousa E. et al. RESPONDIA. Ibero American Spondyloarthropathies Registry: Portuguese Group. Rheumatol Clin 2008;4(S4):68-72 16. Hamdi W, Kaffel D, Ghannouchi MM, et al. Clinical, radiographic and biologic particularities of ankylosing spondylitis in Tunisian patients according to the presence or the absence of the HLA B27 and its sub-types. Revue Medicale de Liège. 2012 Jul-Aug;67(7-8):430-436. 17. Frikhaa F, Marzouka S, Jalloulia M, Friguia M. La spondylarthrite ankylosante: étude d'une série de 83 cas. Revue du Rhumatisme 2006;73:1089-1259 18. Hamdi W, Haouel M, Ghannouchi MM, Mansour A, Kchir MM. Validation of the Ankylosing Spondylitis Quality of Life questionnaire in Tunisian language. La Tunisie Medicale. 2012 Jul;90(7):564-570. 19. Ibn Yacoub Y. Amine B. Laatiris A. et al. Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis. Rheumatol Int 2012;32:357-60. 20. Benamour S, Bettal S, Moudatir A, Jalal O, El Kabli H. Spondylarthropathies : étude de 334 cas Revue Médecine Interne 2001;22:1 21. Diallo S, Ndiaye D, Mbaye PS, Bakary M, Thiam A, Diop TM. L'allèle HLA B27 et les sous-types HLA B27 dans les spondylarthropathies du noir africain du Sénégal. Rev Rhum 2001;68:1081. 22. Ciurea A, Finckh A. Tabac et spondylarthrite. Revu rhum 2013;80:201-203 23. Belkhou1 A, Bakri Y, Yakoubi1 H, Amine M. Prévalence du gène HLA B-27 dans la spondylarthrite ankylosante au Maroc. Rev Mar Rhum 2013;25:38-41 24. Hamdi W, Alaya Z, Ghannouchi MM, Haouel M, Kchir MM. Associated risk factors with worse functional prognosis and hip replacement surgery in ankylosing spondylitis. Joint Bone Spine. 2012 Jan;79(1):94-6. 25. Kim T.-J, Kim T.-H. Aspect clinique de la spondylarthrite ankylosante en Corée.Revue du rhumatisme 2010;77:273-278 26. Deesomchok U, Tumrasvin T. Clinical study of Thai patients with ankylosing spondylitis ; Clin Rheumatol. 1985;4(1):76-82 27. Mijiyawa M. Spondylarthrite ankylosante chez des malades togolais.Revue Médecine tropicale. 1993;53:185-189 28. Gerard S, Le goff B, Maugars Y, Berthelot J-M. Réponse à six mois aux anti-TNF dans les formes axiales de spondylarthropathies selon la satisfaction ou non des critères de New-York et des recommandations de la Société française de rhumatologie. Étude rétrospective de 175 patients. Rev Rhum 2008;75:1220-1228. 29. Dougados M, Etcheto A, Molto A, Alonso S, Bouvet S. Présentation clinique des patients souffrant de rachialgie inflammatoire chronique récente évocatrice de spondyloarthrite : la cohorte Desir. Revue du rhumatisme 2015;82:378-385 30. Kemta Lekpa F, Wendling D, Claudepierre P. Spondyloarthrites : critères, limites, et perspectives à travers l'histoire.Revue du rhumatisme 2015;82:356-359. 31. Astier F, Guillot X, Cook-Moreau J. La spondylarthrite ankylosante : un rhumatisme inflammatoire chronique. Actualités pharmaceutiques 2013;527:1-5 32. Baser S, Cubukcu S, Ozkurt S. Pulmonary involvement starts in early stage ankylosing spondylitis. Scand J Rheumatol 2006;35:325-7. 33. Henchiri I, Hamdi W, Maatallah K, Ferjani H, Kasraoui A, Kaffel D, Kchir MM. Assessment of fracture risk in patients with spondyloarthritis using the FRAX scores. Tunis Med. 2019 Nov;97(11):1235-1239. 34. Rostom S. Nouveautés pour le diagnostic de spondylarthropathie. Rev rhum 2010;77:131-8 35. Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D, Saadellaoui K, Lahmar H, Ghannouchi MM, Azzouz D, Daoud L, Ben Hamida A, Zouari B, Zitouni M, Makni S. HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol Int. 2010 May;30(7):933-9. 36. Ouédraogo DD, Tiéno H, Kaboré H, Palazzo E. Ankylosing spondylitis in rheumatology patients in Ouagadougou. Clin Rheumatol 2009;28:1375-7 37. Awada H, Abi-karam G, BaddouraL R. Clinical radiological, and laboratory findings in Lebanese spondylarthropathy patients according to HLA-B27 status - Joint Bone Spine. Rev Rhum 2000;67:203-7.